PetMed Express Inc (PETS)

Currency in USD
1.210
-0.040(-3.20%)
Closed·
1.2100.000(0.00%)
·
PETS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.2101.270
52 wk Range
1.1504.100
Key Statistics
Prev. Close
1.21
Open
1.23
Day's Range
1.21-1.27
52 wk Range
1.15-4.1
Volume
123.07K
Average Volume (3m)
112.22K
1-Year Change
-55.0186%
Book Value / Share
1.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PETS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.400
Upside
+15.70%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

PetMed Express Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Strong Sell

Analysts 12-Month Price Target:

Average 1.400
(+15.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Morgan Stanley
Sell1.40+15.70%2.15Maintain25/09/2026
Morgan Stanley
Sell2.15+77.69%2.75Maintain29/04/2026

PetMed Express Inc Earnings Call Summary for Q2/2027

  • PetMed Express posted Q2 loss of $0.31/share vs. $0.06 expected; revenue fell 19.4% to $35.8M, missing $62M forecast by 42%.
  • Company slashed advertising spend 52.3% while customer acquisition costs improved 32%, signaling shift to marketing efficiency over growth.
  • Gross margin compressed to 27.4% from 28% amid competitive pressure, higher promotions, and unfavorable product mix in prescription medications.
  • CEO Willard outlined multi-year turnaround focused on core pharmacy, generic expansion, and white-label partnerships; profitability prioritized over growth.
  • No formal guidance provided; management expects transformation to take time, targeting profitability at current size before resuming revenue growth.
Last Updated: 11/11/2026, 08:52 am
Read Full Transcript

Earnings

Latest Release
10/11/2026
EPS / Forecast
-0.31 / -0.06
Revenue / Forecast
35.77M / 62M
EPS Revisions
Last 90 days

PETS Income Statement

Compare PETS to Peers and Sector

Metrics to compare
PETS
Peers
Sector
Relationship
P/E Ratio
−0.9x19.6x9.4x
PEG Ratio
−0.02−0.110.02
Price/Book
1.1x1.1x1.4x
Price / LTM Sales
0.2x0.1x0.8x
Upside (Analyst Target)
15.7%65.3%29.9%
Fair Value Upside
Unlock5.6%14.0%Unlock

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.87M8.89%2.34M
Other Institutional Investors
7.91M37.55%9.88M
Public Companies & Retail Investors
11.28M53.56%14.10M
Total
21.05M100.00%26.32M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
SilverCape Investments Limited12.25%2,579,6963,225
Nina Capital Holdings Inc8.91%1,875,0002,344

People Also Watch

197.00
OSIS
-2.17%
0.6409
CHRS
-21.61%
2.730
FLWS
-2.50%
0.0570
YFOR
-40.13%
7.560
ATYR
-0.26%

FAQ

What Is the PetMed Express (PETS) Stock Price Today?

The PetMed Express stock price today is 1.210 USD.

What Stock Exchange Does PetMed Express Trade On?

PetMed Express is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for PetMed Express?

The stock symbol for PetMed Express is "PETS."

What Is the PetMed Express Market Cap?

As of today, PetMed Express market cap is 25.470M USD.

What Is PetMed Express's Earnings Per Share (TTM)?

The PetMed Express EPS (TTM) is -1.38.

When Is the Next PetMed Express Earnings Date?

PetMed Express will release its next earnings report on 10/02/2027.

From a Technical Analysis Perspective, Is PETS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has PetMed Express Stock Split?

PetMed Express has split 1 times.

How Many Employees Does PetMed Express Have?

PetMed Express has 189 employees.

What is the current trading status of PetMed Express (PETS)?

As of 11/11/2026, PetMed Express (PETS) is trading at a price of 1.210 USD, with a previous close of 1.210 USD. The stock has fluctuated within a day range of 1.210 USD to 1.270 USD, while its 52-week range spans from 1.150 USD to 4.100 USD.

What Is PetMed Express (PETS) Price Target According to Analysts?

The average 12-month price target for PetMed Express is 1.400 USD, with a high estimate of 1.4 USD and a low estimate of 1.4 USD. 0 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Strong Sell. The stock has an +15.70% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.